Last10K.com

Anthem, Inc. (ANTM) SEC Filing 10-Q Quarterly Report for the period ending Thursday, March 31, 2022

SEC Filings

ANTM Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

ANTM Annual Reports

ANTM Quarterly Reports

ANTM Corporate News

Anthem, Inc.

HISTORY TOOLS
CIK: 1156039 Ticker: ANTM

Exhibit 99.1

 

LOGO

 

LOGO

ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2021 RESULTS

 

  •  

Fourth quarter GAAP net income was $4.63 per share, including net negative adjustment items of $0.51 per share. Adjusted net income was $5.14* per share.

 

  •  

Full year GAAP net income was $24.73 per share, including net negative adjustment items of $1.25 per share. Adjusted net income was $25.98* per share.

 

  •  

Fourth quarter operating revenue grew by 14.2% over the prior year quarter to $36.0 billion. Full year operating revenue grew 13.4% year-over-year to $136.9 billion.

 

  •  

Medical enrollment increased by 2.4 million members year-over-year and 303 thousand members in the fourth quarter to 45.4 million members.

 

  •  

Full year 2022 GAAP net income is expected to be greater than $26.75 per share. Adjusted net income is expected to be greater than $28.25* per share.

 

  •  

Quarterly dividend increased by greater than 13% to $1.28 per share.

Indianapolis, Ind. - January 26, 2022 - Anthem, Inc. (NYSE: ANTM) reported fourth quarter and full year 2021 results reflecting strong financial performance, including double-digit top and bottom line growth.

“2021 was another year of strong growth for Anthem as we continued our transformation from a health benefits company to a lifetime trusted partner in health,” said Gail K. Boudreaux, President and CEO. “We begin 2022 with ongoing momentum across all our businesses, and we’re confident in our ability to deliver earnings growth consistent with our long-term targeted range as we innovate for consumers and advance our digital platform for health. Anthem is uniquely positioned to achieve our purpose of improving the Health of Humanity thanks to our 98,000 dedicated employees and their unwavering commitment to the customers and communities we serve.”

 

*

Refer to GAAP reconciliation tables on page 15.

 

1

The following information was filed by Anthem, Inc. (ANTM) on Wednesday, January 26, 2022 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Anthem, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Anthem, Inc..

Continue

Assess how Anthem, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Anthem, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
M & A
Revenue
Legal
Other
Filter Subcategory:
All
Expense
Earnings
Shares
Product
Dividend
Geography
Cash Flow
Income
Other
Inside Anthem, Inc.'s 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information Document
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Comprehensive Income
Consolidated Statements Of Income
Consolidated Statements Of Shareholders' Equity
Accumulated Other Comprehensive Income (Tables)
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss (Reconciliation Of The Components Of Accumulated Other Comprehensive Income) (Details)
Basis Of Presentation And Signficant Accounting Policies Basis Of Presentation And Significant Acconting Policies (Details)
Basis Of Presentation And Significant Accounting Policies
Basis Of Presentation And Significant Accounting Policies (Policies)
Business Acquisitions
Business Acquisitions Business Acquisition (Assets Liabilities Acquired) (Details)
Business Optimization Initiatives
Business Optimization Initiatives (Employee Termination Costs) (Details)
Business Optimization Initiatives (Tables)
Capital Stock
Capital Stock (Fair Values Of Options Granted During The Period Estimated Using Weighted-Average Assumptions) (Details)
Capital Stock (Narrative) (Details)
Capital Stock (Nonvested Restricted Stock Activity Including Restricted Stock Units) (Details)
Capital Stock (Schedule Of Weighted-Average Fair Values Determined For The Periods) (Details)
Capital Stock (Summary Of Cash Dividend Activity) (Details)
Capital Stock (Summary Of Share Repurchases) (Details)
Capital Stock (Summary Of Stock Option Activity) (Details)
Capital Stock (Tables)
Commitments And Contingencies
Commitments And Contingencies (Details)
Debt
Debt (Convertible Debenture Details) (Details)
Debt (Narrative) (Details)
Debt (Tables)
Derivative Financial Instruments
Derivative Financial Instruments (Financial Statement Narrative) (Details)
Earnings Per Share
Earnings Per Share (Denominator For Basic And Diluted Earnings Per Share) (Details)
Earnings Per Share (Narrative) (Details)
Earnings Per Share (Tables)
Fair Value
Fair Value (Carrying And Estimated Fair Values By Level Of Financial Instruments Not Recorded At Fair Value On Consolidated Balance Sheet) (Details)
Fair Value (Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis) (Details)
Fair Value (Reconciliation Of The Beginning And Ending Balances Of Assets Measured At Fair Value On A Recurring Basis Using Level Iii Inputs) (Details)
Fair Value (Tables)
Income Taxes
Income Taxes (Narrative) (Details)
Investments
Investments (Aggregate Fair Value And Gross Unrealized Loss Of Fixed Maturity Securities In An Unrealized Loss Position) (Details)
Investments (Allowance For Credit Loss Rollforward) (Details)
Investments (Amortized Cost And Fair Value Of Fixed Maturity Securities, By Contractual Maturity) (Details)
Investments (Current And Long-Term Fixed Maturity Securities, Available-For-Sale) (Details)
Investments (Current Equity Securities) (Details)
Investments (Narrative) (Details)
Investments (Net Investment Gains/Losses) (Details)
Investments (Tables)
Leases
Leases (Lease And Other Information) (Details)
Leases (Narrative) (Details)
Leases (Reconciliation Of Future Lease Payments To Total Lease Liabilities) (Details)
Leases (Tables)
Medical Claims Payable
Medical Claims Payable (Narrative) (Details)
Medical Claims Payable (Reconciliation Of Net Incurred Medical Claims To Benefit Expense) (Details)
Medical Claims Payable (Reconciliation Of The Beginning And Ending Balances For Medical Claims Payable By Segment) (Details)
Medical Claims Payable (Tables)
Medical Claims Payable Medical Claims Payable (Reconciliation Of The Claims Development To The Claims Liability) (Details)
Organization
Organization (Details)
Segment Information
Segment Information (Financial Data By Reportable Segment) (Details)
Segment Information (Reconciliation Of Income Before Income Tax Expense To Reportable Segments Operating Gain Included In The Consolidated Statements Of Income) (Details)
Segment Information (Reconciliation Of Reportable Segments Operating Revenues To Total Revenues Reported In The Consolidated Statements Of Income) (Details)
Segment Information (Tables)
Segment Information Segment Information (Major Product Revenues For Each Reportable Segment) (Details)
Segment Information Segment Information (Narrative) (Details)
Ticker: ANTM
CIK: 1156039
Form Type: 10-Q Quarterly Report
Accession Number: 0001156039-22-000051
Submitted to the SEC: Wed Apr 20 2022 3:17:33 PM EST
Accepted by the SEC: Wed Apr 20 2022
Period: Thursday, March 31, 2022
Industry: Hospital And Medical Service Plans

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/antm/0001156039-22-000051.htm